本页面由Tiger Trade Technology Pte. Ltd.提供服务

COLLPLANT BIOTECHNOLOGIES LTD

4.26
+0.745021.23%
成交量:12.04万
成交额:48.59万
市值:804.54万
市盈率:-0.46
高:4.44
开:3.58
低:3.50
收:3.51
52周最高:26.80
52周最低:2.64
股本:189.08万
流通股本:113.84万
量比:3.09
换手率:10.58%
股息:- -
股息率:- -
每股收益(TTM):-9.3212
每股收益(LYR):-9.4147
净资产收益率:-161.98%
总资产收益率:-62.95%
市净率:2.73
市盈率(LYR):-0.45

数据加载中...

2026/10/08

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/18

SEC问询函

Form CORRESP - Correspondence
2026/04/15

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2026/03/31

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2026/03/26

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/01/16

SEC问询函

Form CORRESP - Correspondence
2025/10/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/01

SEC问询函

Form CORRESP - Correspondence
2025/06/17

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2025/03/26

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/05/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/04

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/25

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/09/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/24

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/04/18

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]